We are live on ! Find out more
BMEZ icon

BlackRock Health Sciences Trust II

91 hedge funds and large institutions have $477M invested in BlackRock Health Sciences Trust II in 2023 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 23 increasing their positions, 33 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

78% more first-time investments, than exits

New positions opened: 16 | Existing positions closed: 9

7% more funds holding

Funds holding: 8591 (+6)

1.22% more ownership

Funds ownership: 24.54%25.76% (+1.2%)

4% more capital invested

Capital invested by funds: $460M → $477M (+$16.5M)

30% less repeat investments, than reductions

Existing positions increased: 23 | Existing positions reduced: 33

50% less funds holding in top 10

Funds holding in top 10: 21 (-1)

Holders
91
Holders Change
+6
Holders Change %
+7.06%
% of All Funds
1.43%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
16
Increased
23
Reduced
33
Closed
9
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
SCM
1
Saba Capital Management
New York
$107M +$33.3M +2,043,886 +46%
Morgan Stanley
2
Morgan Stanley
New York
$83.8M -$7.09M -435,108 -8%
Bank of America
3
Bank of America
North Carolina
$41.8M -$138K -8,444 -0.3%
UBS Group
4
UBS Group
Switzerland
$34.2M -$1.63M -99,757 -5%
RCM
5
Rivernorth Capital Management
Florida
$26.9M
1CP
6
1607 Capital Partners
Virginia
$26M +$161K +9,855 +0.6%
Invesco
7
Invesco
Georgia
$25.7M -$860K -52,784 -3%
Wells Fargo
8
Wells Fargo
California
$17M -$207K -12,684 -1%
KIM
9
Karpus Investment Management
New York
$14.1M +$549K +33,677 +4%
RJA
10
Raymond James & Associates
Florida
$12.8M -$365K -22,385 -3%
CA
11
Cornerstone Advisors
North Carolina
$11.3M -$2.06M -126,592 -16%
COLIM
12
City of London Investment Management
United Kingdom
$6.44M -$124K -7,599 -2%
CCP
13
Clough Capital Partners
Massachusetts
$4.76M +$759K +46,600 +19%
LPL Financial
14
LPL Financial
California
$4.49M +$969K +59,446 +28%
QC
15
Quantedge Capital
Singapore
$4.18M -$2.87M -176,107 -41%
Stifel Financial
16
Stifel Financial
Missouri
$4.04M -$161K -9,862 -4%
Royal Bank of Canada
17
Royal Bank of Canada
Ontario, Canada
$4.03M -$190K -11,681 -5%
Rockefeller Capital Management
18
Rockefeller Capital Management
New York
$3.81M +$664K +40,726 +21%
PIWA
19
Prevail Innovative Wealth Advisors
Kansas
$3.08M +$3.06M +187,571 New
RJFSA
20
Raymond James Financial Services Advisors
Florida
$3.05M +$565K +34,642 +23%
Ameriprise
21
Ameriprise
Minnesota
$2.78M -$151K -9,248 -5%
WP
22
Woodline Partners
California
$2.37M -$2.62M -160,853 -53%
Lazard Asset Management
23
Lazard Asset Management
New York
$2.37M
JMPWA
24
JP Morgan Private Wealth Advisors
California
$2.15M -$177K -10,835 -8%
Commonwealth Equity Services
25
Commonwealth Equity Services
Massachusetts
$2.13M -$4.82K -296 -0.2%

BMEZ Hedge Fund Activity: Q2 2023 in Review

91 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in BlackRock Health Sciences Trust II (BMEZ) for Q2 2023, worth a combined $477M — up 3.6% from $460M a quarter earlier.

Buyers outnumbered sellers: 16 funds opened new BMEZ positions and 9 closed out — a net gain of 7 holders — while 23 added to existing stakes and 33 trimmed.

The largest buyer was Saba Capital Management, adding an estimated $33.3M. The largest seller was Morgan Stanley, cutting an estimated $7.09M.

  • 91 institutional investors held BlackRock Health Sciences Trust II (BMEZ) as of Q2 2023, up from 85 in Q1 2023.
  • Funds reported $477M of BlackRock Health Sciences Trust II stock for Q2 2023, up 3.6% quarter-over-quarter.
  • 16 funds opened new BlackRock Health Sciences Trust II positions in Q2 2023 and 9 closed out, a net change of +7 holders.
  • The largest BlackRock Health Sciences Trust II buyer in Q2 2023 was Saba Capital Management, an estimated $33.3M added.
  • The largest BlackRock Health Sciences Trust II seller in Q2 2023 was Morgan Stanley, an estimated $7.09M sold.

Based on aggregated 13F filings for Q2 2023.